Lyell Immunopharma, Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
9.75
|
|
Average Rating
|
3.80
|
|
# Strong Buys
|
1
|
|
# Buys
|
2
|
|
# Holds
|
2
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2023-03-31
|
-0.32
|
0.00
|
0.32
|
100.00%
|
|
2022-12-31
|
-0.31
|
0.00
|
0.31
|
100.00%
|
|
2022-09-30
|
-0.31
|
-0.28
|
0.03
|
9.68%
|
|
2022-06-30
|
-0.31
|
-0.15
|
0.16
|
51.61%
|
|
2022-03-31
|
-0.29
|
-0.28
|
0.01
|
3.45%
|
|
2021-12-31
|
-0.28
|
-0.35
|
-0.07
|
-25.00%
|
|
2021-09-30
|
-0.27
|
-0.20
|
0.07
|
25.93%
|
|
2021-06-30
|
-0.36
|
-1.47
|
-1.11
|
-308.33%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
-0.71
|
|
2021-12-31
|
-2.86
|
|
2020-12-31
|
-3.19
|
|
2019-12-31
|
-2.82
|